BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32216327)

  • 1. Chitosan-Ellagic Acid Nanohybrid for Mitigating Rotenone-induced Oxidative Stress.
    Ahlawat J; Neupane R; Deemer E; Sreenivasan ST; Narayan M
    ACS Appl Mater Interfaces; 2020 Apr; 12(16):18964-18977. PubMed ID: 32216327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
    Arulmozhi V; Pandian K; Mirunalini S
    Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ellagic acid protects dopamine neurons from rotenone-induced neurotoxicity via activation of Nrf2 signalling.
    Wei YZ; Zhu GF; Zheng CQ; Li JJ; Sheng S; Li DD; Wang GQ; Zhang F
    J Cell Mol Med; 2020 Aug; 24(16):9446-9456. PubMed ID: 32657027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study.
    Kaur H; Ghosh S; Kumar P; Basu B; Nagpal K
    Life Sci; 2021 Nov; 284():119927. PubMed ID: 34492262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
    Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
    J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ellagic Acid Containing Nanostructured Lipid Carriers for Topical Application: A Preliminary Study.
    Singh Hallan S; Sguizzato M; Pavoni G; Baldisserotto A; Drechsler M; Mariani P; Esposito E; Cortesi R
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32210106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional green synthetized gold nanoparticles/chitosan/ellagic acid self-assembly: Antioxidant, sun filter and tyrosinase-inhibitor properties.
    Gubitosa J; Rizzi V; Fini P; Del Sole R; Lopedota A; Laquintana V; Denora N; Agostiano A; Cosma P
    Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110170. PubMed ID: 31753365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-oxidative effect of mangiferin-chitosan nanoparticles on oxidative stress-induced renal cells.
    Samadarsi R; Dutta D
    Int J Biol Macromol; 2020 May; 151():36-46. PubMed ID: 32070742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ellagic acid in suppressing in vivo and in vitro oxidative stresses.
    Zeb A
    Mol Cell Biochem; 2018 Nov; 448(1-2):27-41. PubMed ID: 29388153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ellagic acid isolated from Clerodendrum viscosum leaves ameliorates iron-overload induced hepatotoxicity in Swiss albino mice through inhibition of oxidative stress and the apoptotic pathway.
    Shendge AK; Basu T; Panja S; Chaudhuri D; Mandal N
    Biomed Pharmacother; 2018 Oct; 106():454-465. PubMed ID: 29990833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ellagic acid mitigates rotenone-induced damage via modulating mitochondria function in Drosophila melanogaster.
    Adedara AO; Otenaike TA; Farodoye OM; Abolaji AO
    J Biochem Mol Toxicol; 2023 Jun; 37(6):e23332. PubMed ID: 37294177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ellagic acid encapsulated chitosan nanoparticles as anti-hemorrhagic agent.
    Gopalakrishnan L; Ramana LN; Sethuraman S; Krishnan UM
    Carbohydr Polym; 2014 Oct; 111():215-21. PubMed ID: 25037345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Nanoformulation of Ellagic Acid is Promising in Restoring Oxidative Homeostasis in Rat Brains with Alzheimer's Disease.
    Harakeh S; Qari MH; Ramadan WS; Al Jaouni SK; Almuhayawi MS; Al Amri T; Ashraf GM; Bharali DJ; Mousa SA
    Curr Drug Metab; 2021; 22(4):299-307. PubMed ID: 33327909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant action of ellagic acid ameliorates paraquat-induced A549 cytotoxicity.
    Kim YS; Zerin T; Song HY
    Biol Pharm Bull; 2013; 36(4):609-15. PubMed ID: 23546295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ellagic acid mitigates SNO-PDI induced aggregation of Parkinsonian biomarkers.
    Kabiraj P; Marin JE; Varela-Ramirez A; Zubia E; Narayan M
    ACS Chem Neurosci; 2014 Dec; 5(12):1209-20. PubMed ID: 25247703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ellagic acid, a natural polyphenol, on alcohol-induced prooxidant and antioxidant imbalance: a drug dose dependent study.
    Devipriya N; Srinivasan M; Sudheer AR; Menon VP
    Singapore Med J; 2007 Apr; 48(4):311-8. PubMed ID: 17384878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Molecular Weight Sulfated Chitosan: Neuroprotective Effect on Rotenone-Induced In Vitro Parkinson's Disease.
    Manigandan V; Nataraj J; Karthik R; Manivasagam T; Saravanan R; Thenmozhi AJ; Essa MM; Guillemin GJ
    Neurotox Res; 2019 Apr; 35(3):505-515. PubMed ID: 30426393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ellagic Acid: A Logical Lead for Drug Development?
    Shakeri A; Zirak MR; Sahebkar A
    Curr Pharm Des; 2018; 24(2):106-122. PubMed ID: 29141541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ellagic acid reduces methotrexate-induced apoptosis and mitochondrial dysfunction via up-regulating Nrf2 expression and inhibiting the IĸBα/NFĸB in rats.
    Ebrahimi R; Sepand MR; Seyednejad SA; Omidi A; Akbariani M; Gholami M; Sabzevari O
    Daru; 2019 Dec; 27(2):721-733. PubMed ID: 31736017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ellagic acid protects hepatocytes from damage by inhibiting mitochondrial production of reactive oxygen species.
    Hwang JM; Cho JS; Kim TH; Lee YI
    Biomed Pharmacother; 2010 Apr; 64(4):264-70. PubMed ID: 20347566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.